Authors: Bonfanti, P Landonio, S Ricci, E Martinelli, C Fortuna, P Faggion, I Quirino, T

Citation: P. Bonfanti et al., Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy, J ACQ IMM D, 27(3), 2001, pp. 316-318

Authors: Bonfanti, P Ricci, E Landonio, S Valsecchi, L Timillero, L Faggion, I Quirino, T

Citation: P. Bonfanti et al., Predictors of protease inhibitor-associated adverse events, BIOMED PHAR, 55(6), 2001, pp. 321-323

Authors: Bonfanti, P Gabbuti, A Carradori, S Pusterla, L Parazzini, F Landonio, S Quirino, T

Citation: P. Bonfanti et al., Osteonecrosis in protease inhibitor-treated patients, ORTHOPEDICS, 24(3), 2001, pp. 271-272

Authors: Bonfanti, P Valsecchi, L Parazzini, F Carradori, S Pusterla, L Fortuna, P Timillero, L Alessi, F Ghiselli, G Gabbuti, A Di Cintio, E Martinelli, C Faggion, I Landonio, S Quirino, T

Citation: P. Bonfanti et al., Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study, J ACQ IMM D, 23(3), 2000, pp. 236-245

Authors: Quirino, T Niero, F Ricci, E Pusterla, L Carradori, S Gabbuti, A Iemoli, E Landonio, S Faggion, I Bonfanti, P

Citation: T. Quirino et al., HAART tolerability: post-exposure prophylaxis in healthcare workers versustreatment in HIV-infected patients, ANTIVIR TH, 5(3), 2000, pp. 195-197

Authors: Bonfanti, P Pusterla, L Parazzini, F Libanore, M Cagni, AE Franzetti, M Faggion, I Landonio, S Quirino, T

Citation: P. Bonfanti et al., The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study, BIOMED PHAR, 54(1), 2000, pp. 45-49